Fig. 4From: The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III studyBox plot depicting the International Prostate Symptom Score (IPSS) in the groups (Group A—Mictalase® versus Group B—controls) at baseline, 15th and 30th postoperative day assessmentsBack to article page